Merck & Company Inc (MRK)

Fixed asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 64,168,000 63,174,000 62,479,000 61,402,000 60,114,000 59,314,000 58,311,000 57,869,000 59,283,000 58,974,000 57,169,000 53,978,000 48,704,000 46,131,000 43,906,000 41,857,000 43,287,000 36,488,000 37,956,000 40,363,000
Property, plant and equipment US$ in thousands 23,779,000 23,446,000 23,221,000 23,045,000 23,051,000 22,526,000 22,231,000 21,758,000 21,422,000 20,424,000 20,059,000 19,747,000 19,279,000 18,565,000 18,064,000 18,295,000 17,000,000 16,919,000 15,789,000 15,269,000
Fixed asset turnover 2.70 2.69 2.69 2.66 2.61 2.63 2.62 2.66 2.77 2.89 2.85 2.73 2.53 2.48 2.43 2.29 2.55 2.16 2.40 2.64

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $64,168,000K ÷ $23,779,000K
= 2.70

Merck & Company Inc's fixed asset turnover ratio has shown a relatively stable trend over the period from March 31, 2020, to December 31, 2024, ranging between 2.16 and 2.89. The fixed asset turnover ratio measures how efficiently the company is generating revenue from its fixed assets. A higher ratio indicates that the company is generating more revenue per dollar of investment in fixed assets.

Throughout the period, Merck's fixed asset turnover ratio has generally remained above 2, which suggests that the company has been effectively utilizing its fixed assets to generate sales. The peak ratio of 2.89 in September 30, 2022, indicates a particularly efficient use of fixed assets to generate revenue. On the other hand, the decrease in the ratio to 2.16 on September 30, 2020, may suggest a lesser efficiency in utilizing fixed assets during that period.

Overall, the consistent range of fixed asset turnover ratios for Merck & Company Inc reflects the company's ability to efficiently generate revenue from its investment in fixed assets, which is a positive indicator of operational efficiency and effective asset management.


See also:

Merck & Company Inc Net Fixed Asset Turnover (Quarterly Data)